BOSTON–(BUSINESS WIRE)–Instem will launch its unified, AI-enabled Provantis platform in mid-2027, connecting preclinical study execution, analysis and SEND submission.

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.